Phenylketonuria (PKU) and Related Disorders
USMLE Step 1 trap: Confuses lens dislocation direction: downward in homocystinuria vs upward in Marfan syndrome. Homocystinuria causes downward lens dislocation, while Marfan syndrome causes upward (superior) lens dislocation — a key distinguishing feature.
Phenylketonuria and its related amino acid disorders are a high-yield cluster on USMLE Step 1 — not because any single disease is complex, but because the exam loves to blur them together. The core concept is a shared biochemical pathway: phenylalanine → tyrosine → downstream products (melanin, catecholamines, homogentisate). Each disorder represents a block at a different enzyme in this chain, and the exam tests whether you can map the clinical phenotype back to the correct enzymatic defect. PKU itself is tested on recall (defect, presentation, diet), but the related disorders — homocystinuria, alkaptonuria, albinism, MSUD — are tested by making you distinguish them from each other or from similar conditions like Marfan syndrome.
The trickiest part of this topic is that several disorders share surface features. Homocystinuria and Marfan syndrome both cause tall stature and lens dislocation, but the direction of dislocation is opposite — and USMLE Step 1 will absolutely put that in a vignette and expect you to know the difference. Similarly, albinism and PKU both involve the phenylalanine/tyrosine pathway, but at completely different enzymatic steps. Students who learn these diseases in isolation (just memorizing bullet points per disease) get burned on questions that require cross-comparison.
Alkaptonuria is the most commonly missed of the group — students forget the full triad and reduce it to 'dark urine,' missing ochronosis and arthritis. MSUD is tested on its specific enzyme defect (branched-chain α-keto acid dehydrogenase) and the characteristic maple syrup odor. For all of these, the exam rewards students who understand the pathway logic, not just the isolated facts.
Well-covered in most decks — the challenge is retention, not exposure.
Common misconceptions
What the exam tests
- PKU: Know the enzyme defect (phenylalanine hydroxylase or BH4 cofactor), the classic presentation (intellectual disability, fair skin, musty/mousy odor, seizures), and the correct dietary management — phenylalanine restriction with tyrosine supplementation, not total protein elimination.
- MSUD: Identify the deficient enzyme (branched-chain α-keto acid dehydrogenase), the substrates that accumulate (leucine, isoleucine, valine and their keto acids), the maple syrup urine/sweat odor, and that treatment is dietary restriction of branched-chain amino acids.
- Homocystinuria: Distinguish between the two main enzyme defects (cystathionine synthase deficiency vs. decreased affinity for pyridoxal phosphate), recognize the Marfan-like phenotype (tall, long limbs, lens dislocation), and know that lens dislocation goes DOWNWARD — not upward as in Marfan syndrome.
- Albinism vs. alkaptonuria: Map each to its correct enzyme defect — albinism is tyrosinase deficiency (no melanin production), alkaptonuria is homogentisate oxidase deficiency — and recognize the full alkaptonuria triad: dark urine on standing, ochronosis (bluish-black pigmentation of connective tissue), and early-onset arthritis.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →